Mankind Pharma Q1 FY26 Net Profit Falls 17% to ₹378 Cr; Declares ₹5 Dividend

Mankind Pharma reported a 17% year-on-year drop in consolidated net profit to ₹378 crore in Q1 FY26, despite an 11% rise in revenue. The company also declared a ₹5 per…

Mankind Pharma inks pact with Innovent for immunotherapy drug in India

Mankind Pharma Ltd and Innovent Biologics on Thursday announced a partnership to exclusively license and commercialise innovative immunotherapy drug Sintilimab, used in the treatment of cancer, in the Indian market.…

Mankind Pharma inks pact with Takeda to commercialise acidity drug in India

Delhi-based Mankind Pharma Limited has signed a non-exclusive patent licence agreement with Takeda Pharmaceuticals for commercialising acidity drug Vonoprazan in the Indian market. The agreement allows Mankind Pharma to launch…

Mankind Pharma Donated Rs 250 Crore To COVID-19 Relief After A Miscalculation Of Zero

In a candid conversation with YouTuber Ranveer Allahabadia on The Ranveer Show, Rajeev Juneja, the Managing Director of Mankind Pharma, shared a tale of philanthropy spurred by a miscalculation. The…

Mankind Pharma reduces price of heart drug NEPTAZ in India

One Of the Best Pharma Company Mankind reduced the price of  heart drug NEPTAZ in India. Mankind has announced a price reduction of up to 70 per cent across different…